Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical Innovation

Area of Science:

• Pharmaceutical Sciences
• Computational Biology
• Drug Discovery

Background:

• Drug discovery is a lengthy, expensive, and high-risk process, often exceeding a decade from target identification to clinical application.
• Traditional methods face significant challenges in efficiency and success rates.

Purpose of the Study:

• To critically examine the evolving role of Artificial Intelligence (AI) in modern drug discovery.
• To highlight AI's impact on pharmaceutical formulation and personalized medicine.
• To discuss challenges and future directions for AI in pharmaceutics.

Main Methods:

• Review of advancements in machine learning, deep learning, and natural language processing for drug discovery.
• Examination of AI-driven insilico platforms for predicting toxicity, pharmacokinetics, and developability.
• Analysis of collaborative models between AI developers and the pharmaceutical industry.

Main Results:

• AI significantly enhances efficiency and accuracy in target identification, hit finding, lead optimization, and drug repurposing.
• AI platforms improve early-stage predictability, reducing attrition rates in late-stage development.
• AI is expanding its impact on pharmaceutical formulation and personalized medicine.

Conclusions:

• AI is revolutionizing drug discovery, offering unprecedented speed and precision.
• Addressing challenges like algorithmic transparency, data quality, and regulatory acceptance is crucial for realizing AI's full potential.
• Collaboration and continued innovation are key to accelerating AI-driven translational outcomes in pharmaceutics.